ArticleBMC ophthalmology2025
Clinical comparison of epiretinal membrane surgery using Sharkskin forceps versus conventional forceps.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate and compare the outcomes between eyes that underwent pars plana vitrectomy (PPV) for epiretinal membrane (ERM) using the Sharkskin forceps versus conventional forceps.
methodsThe prospective comparative study involved 38 eyes with ERM between November 2022 and May 2023. Nineteen eyes were treated with PPV and membrane peeling using the Grieshaber Sharkskin forceps, while the other 19 eyes were treated with conventional forceps. The number of grasps for initial membrane mobilization, duration for complete membrane peeling, best-corrected visual acuity (BCVA) and central macular thickness (CMT) before PPV and within three-month follow up, adverse events were recorded.
resultsAll patients successfully underwent ERM removal. The Sharkskin group completed membrane removal in 198.84 s with 8.21 grasps for initial membrane mobilization, compared to 250.95 s and 10.53 grasps in the conventional group (p
conclusionThe use of Sharkskin forceps in ERM surgery demonstrated comparable clinical outcomes to conventional forceps, while causing less retinal damage. These findings suggest that Sharkskin forceps can be safely and effectively utilized in vitreoretinal interface surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.